Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension

Hypertension

Volumn 27, Issue 3 II, 1996, Pages 752-759

  Dominiczak, Anna F ^a   Devlin, Alison M ^a   Lee, Wai K ^a   Anderson, Niall H ^a   Bohr, David F ^b   Reid, John L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

angiotensin II; cell cycle; hypertension, genetic; hypertrophy; muscle, smooth, vascular; rats, stroke prone SHR

Indexed keywords

ANGIOTENSIN; LOSARTAN; N(G) NITROARGININE METHYL ESTER; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL CYCLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HEART HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOGENESIS; POLYPLOIDY; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0029983368     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.27.3.752     Document Type: Conference Paper

References (44)

1. Ferrara LA, Mancini M, Celentano A, Galderisi M, Iannuzzi R, Marotta T, Gaeta I. Early changes of the arterial carotid wall in uncomplicated primary hypertensive patients: study by ultrasound high-resolution B-mode imaging. Arterioscler Thromb. 1994;14: 1290-1296.
2. Girerd X, Mourad JJ, Copie X, Moulin C, Acar C, Safar M, Laurent S. Noninvasive detection of an increased vascular mass in untreated hypertensive patients. Am J Hypertens. 1994;7:1076-1084.
3. Roman MJ, Pickering TG, Pini A, Schwartz JE, Devereux RB. Prevalence and determinants of cardiac and vascular hypertrophy in hypertension. Hypertension. 1995;265:369-373.
4. Devlin AM, Gordon JF, Davidson AO, Clark JS, Hamilton CA, Morton JJ, Campbell AM, Reid JL, Dominiczak AF. The effect of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats. J Hypertens. 1995;13:211-218.
5. Rapp JP. Dissecting the primary causes of genetic hypertension in rats. Hypertension. 1991;18(suppl I):I-18-I-28.
6. Geisterfer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy but not hyperplasia of cultured rat aortic smooth muscle cells. Circ Res. 1990;62:749-756.
7. Paquet JL, Bandomin-Legros M, Brunelle G, Meyer P. Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens. 1990;8:505-572.
8. Aceto JF, Baker KM. (Sar 1) angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol. 1990;258:H806-H813.
9. Timmermans PB, Wong PC, Chiu AT, Herblin WF. Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol Sci. 1991;12: 55-61.
10. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.
11. Owens GK. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. Am J Physiol. 1989;257:H1755-H1765.
12. Engelmann G, Vitullo J, Gerrity R. Age-related changes in ploidy levels and biochemical parameters in cardiac myocytes isolated from spontaneously hypertensive rats. Circ Res. 1986;58:137-147.
13. Brodsky W, Uryvaeva IV. Cell polyploidy: its relation to tissue growth and function. Int Rev Cytol. 1977;50:275-332.
14. Owens GK, Schwartz SM. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat: role of cellular hypertrophy, hyperploidy and hyperplasia. Circ Res. 1982;51:280-289.
15. Lombardi DM, Owens GK, Schwartz S. Ploidy in mesenteric vessels of aged spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 1989;13:475-479.
16. Owens GK. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension. 1987;9:178-187.
17. Owens GK, Schwartz SM. Vascular smooth muscle cell hypertrophy and hyperploidy in Goldblatt hypertensive rats. Circ Res. 1983;53: 491-501.
18. Lichtenstein AH, Brecher P, Chobanian AV. Effects of deoxycorticosterone-salt hypertension on cell ploidy in the rat aorta. Hypertension. 1986;8(suppl II):II-50-II-54.
19. Rapp JP. A paradigm for identification of primary genetic causes of hypertension in rats. Hypertension. 1983;5(suppl II):II-198-II-203.
20. Devlin AM, Davidson AO, Gordon JF, Campbell AM, Morton JJ, Reid JL, Dominiczak AF. Vascular smooth muscle polyploidy in genetic hypertension: the role of angiotensin II. J Hum Hypertens. 1995;9:497-500.
21. Black MJ, Bertram JF, Campbell JH, Campbell GR. Angiotensin II induces cardiovascular hypertrophy in perindopril-treated rats. J Hypertens. 1995;13:683-692.
22. Wu JN, Berecek KH. Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension. 1993;22: 139-146.
23. Gibbons GH, Dzau VJ. The emerging concept of vascular remodelling. N Engl J Med. 1994;20:1431-1437.
24. Garg VC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
25. Arnal JF, El Amrani A, Chatellier G, Menard J, Michael JB. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension. 1993;22:380-387.
26. Rhaleb NE, Yang XP, Scicli AG, Carretero OA. Role of kinins and nitric oxide in the antihypertensive effect of ramipril. Hypertension. 1994;23:865-868.
27. Dominiczak AF, McLaren Y, Kusel JR, Ball DL, Goodfriend TL, Bohr DF, Reid JL. Lateral diffusion and fatty acid composition in vascular smooth muscle membrane from stroke-prone spontaneously hypertensive rats. Am J Hypertens. 1993;6:1003-1008.
28. Davidson AO, Schork N, Jaques BC, Kelman AW, Sutcliffe RG, Reid JL, Dominiczak AF. Blood pressure in genetically hypertensive rats: influence of the Y chromosome. Hypertension. 1995;26: 452-459.
29. Vindelov LL, Christensen IJ, Nissen NI. A detergent trypsin method of preparation of nuclei for flow cytometric DNA analysis. Cytometry. 1983;3:323-327.
30. Morton JJ, Webb DJ. Measurements of plasma angiotensin II. Clin Sci. 1985;68:483-484.
31. Dominiczak AF, Lindpaintner K. Genetics of hypertension: a current appraisal. News Physiol Sci. 1994;9:246-251.
32. Safar ME. Hemodynamic changes in elderly hypertensive patients. Am J Hypertens. 1993;6:20S-23S.
33. James MA, Watt PAC, Potter JF, Thurston H, Swales JD. Pulse pressure and resistance artery structure in the elderly. Hypertension. 1995;26:301-306.
34. Baker KM, Chemin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol. 1990;259:H324-H332.
35. Frohlich ED, Tarazi RC. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol. 1979;44:959-963.
36. Zhou J, Allen AM, Yamada H, Sun Y, Mendelsohn FAO. Localization and properties of the angiotensin converting enzyme and angiotensin receptors in the heart. In: Lindpaintner K, Ganten D, eds. The Cardiac Renin-Angiotensin System. Armonk, NY: Futura Publishing Co Inc; 1994:63-83.
37. Brown L, Sernia C. Angiotensin receptors in cardiovascular disease. Clin Exp Pharmacol Physiol. 1994;21:811-818.
38. Black MJ, Adams MA, Bobik A, Campbell JH, Campbell GR. Effect of enalapril on aortic smooth muscle polyploidy in the spontaneously hypertensive rat. J Hypertens. 1989;7:997-1003.
39. Owens GK. Differential effects of antihypertensive drug therapy on vascular smooth muscle hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat. Circ Res. 1985;56:525-536.
40. Campbell JD, Kledis A, Duncan AM. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension. 1994;23:439-449.
41. Safar ME, Laurent SL, Bouthier JD, London GM, Mimran AR. Effect of converting enzyme inhibitors on hypertensive large arteries in humans. J Hypertens Suppl. 1986;4(5):S285-S289.
42. Bentos A, Topouchian J, Ricard S, Gautier S, Bonnardeaux A, Asmar R, Poirier O, Soubrier F, Safar M, Cambien F. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension. 1995;26:44-47.
43. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BLM, Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 1995;337:748-750.
44. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature. 1995;337:744-747.